Dividend Seeker.
Fund holdings lookup
Request failed

As of the latest SEC filings, Silence Therapeutics plc (SLN) is held by 8 institutional funds. The largest fund shareholder is iShares Biotechnology ETF (IBB), holding an estimated $913,359.51 in market value, representing 0.01% of its portfolio.

Funds holding Silence Therapeutics plc (SLN)

Source: SEC Form N-PORT institutional portfolio disclosures

Ticker:
SLN
CIK:
0001479615
8 results
Fund Type Manager Weight Market Value Shares
Report Date
Filing Date
IBB
iShares Biotechnology ETF
ETF BlackRock / iShares 0.01% $913,359.51 173,313 Mar 31, 2026 May 28, 2026
FNCMX
Fidelity Nasdaq Composite Index Fund
MF Fidelity 0.00% $160,686.72 29,538 Feb 28, 2026 Apr 24, 2026
GWX
State Street(R) SPDR(R) S&P(R) International Small Cap ETF
ETF State Street (SPDR) 0.01% $49,717.18 9,434 Mar 31, 2026 May 28, 2026
SNTCX
Steward Values Enhanced International Fund
MF Independent / Boutique 0.01% $42,398.00 5,800 Apr 30, 2026 Jun 25, 2026
IBBQ
Invesco Nasdaq Biotechnology ETF
ETF Invesco 0.02% $14,258.24 2,621 Feb 28, 2026 Apr 28, 2026
BIB
ProShares Ultra Nasdaq Biotechnology
ETF ProShares 0.01% $11,799.36 2,169 Feb 28, 2026 Apr 24, 2026
BXMYX
Blackstone Alternative Multi-Strategy Fund
MF Independent / Boutique 0.00% $5,270.00 1,000 Mar 31, 2026 May 27, 2026
SPGM
State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF
ETF State Street (SPDR) 0.00% $0.00 2 Mar 31, 2026 May 28, 2026
Advertisement (320x50)